Concepedia

Laura Esparza

LE

Statistics

Publications

12

Citations

304

H-Index

12

Active since

1982

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anderson Hospital

Breast Cancer Care

The University of Texas System

Laura Esparza is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1982–2009

12

Publications

12

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

Karen E. Hoffman, Frankie A. Holmes, Giuseppe Fraschini et al. · Cancer Chemotherapy and Pharmacology · 1995 · 58 citations

, , +14

Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma

Frank C. Schell, H. Y. Yap, G. N. Hortobágyi et al. · Cancer Chemotherapy and Pharmacology · 1982 · 50 citations

, , +12

Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.

L. Lamki, Aman U. Buzdar, S. Eva Singletary et al. · PubMed · 1991 · 43 citations

, , +17

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

John A. Benvenuto, Robert A. Newman, Gary S. Bignami et al. · Investigational New Drugs · 1992 · 35 citations

, , +16

Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer

H. Y. Yap, Laura Esparza, George R. Blumenschein et al. · Cancer Treatment Reviews · 1983 · 18 citations

, , +14

1–5 of 12